Description
INTRODUCTION ABOUT FIBNIB 150 CAPSULE
FIBNIB 150 CAPSULE contains Nintedanib which belongs to the group of medicines called Kinase inhibitors. It is used to manage idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). It is used in combination with docetaxel in adult patients for the management of locally advanced metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology after first line chemotherapy.
Idiopathic Pulmonary Fibrosis (IPF) is a chronic lung disorder in which the lungs become scarred and breathing becomes increasingly difficult. Symptoms include shortness of breath, persistent dry cough, tiredness, loss of appetite, weight loss, rounded and swollen fingertips (clubbed fingers).
Before taking FIBNIB 150 CAPSULE inform your doctor if you have liver, heart or bleeding problems, history of blood clots or had a recent surgery in stomach. FIBNIB 150 CAPSULE is not recommended for use in pregnant women unless advised by your doctor and it is not recommended for use in breastfeeding women as it may pass through breast milk. Before starting management with FIBNIB 150 CAPSULE, your doctor may want you to take several blood tests to understand your existing condition.
FIBNIB 150 CAPSULE should be used with caution in elderly patients (aged 65 years and above). The most common side effects of taking FIBNIB 150 CAPSULE are diarrhoea, nausea, vomiting, stomach pain, loss of appetite, headache, weight loss and high blood pressure. Consult your doctor if any of the symptom worsens.
USES OF FIBNIB 150 CAPSULE
- Manage idiopathic pulmonary fibrosis (IPF)
- Manage chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype
- To slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)
HOW FIBNIB 150 CAPSULE WORKS
FIBNIB 150 CAPSULE is a tyrosine kinase inhibitor (TKI) which works by blocking the enzymes in cells of the lungs called tyrosine kinases. Blocking these enzymes helps to decrease fibrous tissue formation in the lungs, thereby stops the symptoms of lung disease getting worse.
DIRECTIONS FOR USE
Take FIBNIB 150 CAPSULE as advised by your physician. Swallow the medicine with a glass of water. Do not crush, chew, or open the medicine. Your doctor will decide the correct dose and duration for you based upon your age, body weight and disease condition. Do not stop taking FIBNIB 150 CAPSULE unless your doctor advises you to stop.
SIDE EFFECTS OF FIBNIB 150 CAPSULE
COMMON
- diarrhoea
- nausea, vomiting
- stomach pain
- liver problems
- decreased appetite
- headache
- weight loss
- high blood pressure
RARE
Stop taking FIBNIB 150 CAPSULE and contact your doctor immediately if you experience any of the following side effects:
- severe liver problems symptoms such as yellowing of your skin or white part of your eyes (jaundice), dark or brown (tea colored) urine, pain on the upper right side of your stomach area (abdomen), bleeding or bruising more easily than normal, feeling tired, or loss of appetite
- severe diarrhoea, nausea and vomiting
- signs of heart attack such as chest pain or pressure, pain in arms, back, neck or jaw, or shortness of breath
- signs of stroke such as numbness or weakness on one side of your body, trouble talking, headache or dizziness
- signs of bleeding problem such as unusual bleeding, bruising, or wounds that do not heal
- signs of tear in stomach or intestinal wall (perforation) such as pain or swelling in stomach area
- signs of increased protein in urine (proteinuria) such as foamy urine, swelling of the hands, arms, legs, or feet or sudden weight gain
Reviews
There are no reviews yet.